Abstract

Iron deficiency is the most prevalent micronutrient deficiency worldwide. Whereas dietary calcium is known to reduce the bioavailability of iron, the molecular basis of this interaction is not understood. We tested the hypothesis that divalent metal-ion transporter-1 (DMT1)—the principal or only mechanism by which nonheme iron is taken up at the intestinal brush border—is shared also by calcium. We expressed human DMT1 in RNA-injected Xenopus oocytes and examined its activity using radiotracer assays and the voltage clamp. DMT1 did not mediate 45Ca 2+ uptake. Instead, we found that Ca 2+ blocked the Fe 2+-evoked currents and inhibited 55Fe 2+ uptake in a noncompetitive manner ( K i ≈ 20 mM). The mechanism of inhibition was independent of voltage and did not involve intracellular Ca 2+ signaling. The alkaline-earth metal ions Ba 2+, Sr 2+, and Mg 2+ also inhibited DMT1-mediated iron-transport activity. We conclude that Ca 2+ is a low-affinity noncompetitive inhibitor—but not a transported substrate—of DMT1, explaining in part the effect of high dietary calcium on iron bioavailability.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.